Ozempic May Lower Stroke And Alzheimer's Risk By Up To 49%
A new study published in Neurology Genetics suggests a potential link between GLP-1 receptor agonists, such as Ozempic, and a reduced risk of stroke and Alzheimer's disease. Researchers caution that these findings do not yet prove the drug prevents these conditions.
Why it matters
It highlights the expanding medical research into the secondary health benefits of weight-loss drugs beyond metabolic regulation.
Ozempic, the globally popular weight loss drug, might be capable of a lot beyond making you shed kilos off the scale. Scientists are now investigating whether medicines that mimic the GLP-1 hormone could also offer benefits for brain health.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in